Literature DB >> 15345236

Catheter-related infections.

Philippe Eggimann1, Hugo Sax, Didier Pittet.   

Abstract

Nosocomial infections are a leading cause of morbidity and mortality among hospitalized patients. These infections have made newspaper headlines recently in many countries, and both patients and their relatives are now perfectly aware of their existence and of the risks which are inherent to any medical activity. However, significant improvements in the knowledge of the pathophysiology and epidemiology of nosocomial infections allow us to prevent them efficiently. Accordingly, they should no longer be considered as an inevitable tribute to pay to the continuous progress of medicine, but as a real challenge in the process of improving the quality of patient care. This is particularly the case for bloodstream infections, of which at least 80% are considered to be catheter associated. This paper reviews the epidemiology and impact of infections associated with the use of intravenous catheters. Principles of therapy are reviewed, as well as major aspects of prevention.

Entities:  

Mesh:

Year:  2004        PMID: 15345236     DOI: 10.1016/j.micinf.2004.05.018

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  15 in total

1.  Ultraviolet-C irradiation for prevention of central venous catheter-related infections: an in vitro study.

Authors:  Tianhong Dai; George P Tegos; Tyler G St Denis; Don Anderson; Ed Sinofsky; Michael R Hamblin
Journal:  Photochem Photobiol       Date:  2010-11-12       Impact factor: 3.421

2.  Central venous catheter-associated bloodstream infections occurring in Canadian intensive care units: A six-month cohort study.

Authors:  Donna Holton; Shirley Paton; John Conly; Joanne Embree; Geoffrey Taylor; William Thompson
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-05       Impact factor: 2.471

3.  Epistatic relationships between sarA and agr in Staphylococcus aureus biofilm formation.

Authors:  Karen E Beenken; Lara N Mrak; Linda M Griffin; Agnieszka K Zielinska; Lindsey N Shaw; Kelly C Rice; Alexander R Horswill; Kenneth W Bayles; Mark S Smeltzer
Journal:  PLoS One       Date:  2010-05-24       Impact factor: 3.240

Review 4.  [Infections and sepsis from intravascular catheters].

Authors:  A F Widmer
Journal:  Internist (Berl)       Date:  2005-06       Impact factor: 0.743

5.  A Tick Antivirulence Protein Potentiates Antibiotics against Staphylococcus aureus.

Authors:  Nabil M Abraham; Lei Liu; Brandon L Jutras; Kristen Murfin; Ali Acar; Timur O Yarovinsky; Erica Sutton; Martin Heisig; Christine Jacobs-Wagner; Erol Fikrig
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

6.  New heparinizable modified poly(carbonate urethane) surfaces diminishing bacterial colonization.

Authors:  Luigi De Nardo; Silvia Farè; Valentina Di Matteo; Eliana Cipolla; Enrica Saino; Livia Visai; Pietro Speziale; Maria Cristina Tanzi
Journal:  J Mater Sci Mater Med       Date:  2007-08-01       Impact factor: 3.896

7.  A novel approach to reduce catheter-related infection using sustained-release basic fibroblast growth factor for tissue regeneration in mice.

Authors:  Keiichi Hirose; Akira Marui; Yoshio Arai; Takamasa Nomura; Kozo Kaneda; Yu Kimura; Tadashi Ikeda; Masatoshi Fujita; Masao Mitsuyama; Yasuhiko Tabata; Masashi Komeda
Journal:  Heart Vessels       Date:  2007-07-20       Impact factor: 2.037

8.  In vivo imaging of infection using a bacteria-targeting optical nanoprobe.

Authors:  Ewin N Tang; Ashwin Nair; David W Baker; Wenjing Hu; Jun Zhou
Journal:  J Biomed Nanotechnol       Date:  2014-05       Impact factor: 4.099

9.  Pediatric patients with intravascular devices: polymicrobial bloodstream infections and risk factors.

Authors:  Wes Onland; Dasja Pajkrt; Cathy Shin; Stana Fustar; Teresa Rushing; Wing-Yen Wong
Journal:  J Pathog       Date:  2011-04-18

Review 10.  Economic evaluation and catheter-related bloodstream infections.

Authors:  Kate Halton; Nicholas Graves
Journal:  Emerg Infect Dis       Date:  2007-06       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.